Medication Therapy Management and Pharmacogenetics on Oral Anticoagulants
Not Applicable
- Conditions
- Health Condition 1: D683- Hemorrhagic disorder due to circulating anticoagulants
- Registration Number
- CTRI/2021/01/030250
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients prescribed with anticoagulants in surgery, cardio-thoracic and cardiology units (Both in-patients and out-patients)
Exclusion Criteria
Critically ill patients
Patients with psychiatric problems
Pregnant women
Patients not willing to participate in the study
For PGx study: Other anticoagulants, inhibitors and inducers of warfarin excluded
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Impact of MTM services <br/ ><br>Knowledge and Adherence <br/ ><br>Pharmacogenetics of Warfarin <br/ ><br>INR monitoring <br/ ><br>Timepoint: 0, 4, 8 months
- Secondary Outcome Measures
Name Time Method Direct costs incurred <br/ ><br> <br/ ><br>Timepoint: 0, 4, 8 months